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AbstrACt
Introduction Behavioural and mental disorders have 
become a public health crisis and by 2020 may surpass 
physical illness as a major cause of disability. Early 
prevention is key. Two Incredible Years (IY) parent 
programmes that aim to enhance child well-being and 
development, IY Infant and IY Toddler, will be delivered and 
evaluated in a proportionate universal intervention model 
called Enhancing Social-Emotional Health and Wellbeing in 
the Early Years (E-SEE) Steps. The main research question 
is: Does E-SEE Steps enhance child social emotional 
well-being at 20 months when compared with services as 
usual?
Methods and analysis E-SEE Steps will be delivered in 
community settings by Early Years Children’s Services and/
or Public Health staff across local authorities. Parents of 
children aged 8 weeks or less, identified by health visitors, 
children’s centre staff or self-referral, are eligible for 
participation in the trial. The randomisation allocation ratio 
is 5:1 (intervention to control). All intervention parents will 
receive an Incredible Years Infant book (universal level), 
and may be offered the Infant and/or Toddler group-based 
programme/s—based on parent depression scores on 
the Patient Health Questionnaire or child social emotional 
well-being scores on the Ages and Stages Questionnaire: 
Social Emotional, Second Edition (ASQ:SE-2). Control group 
parents will receive services as usual. A process and 
economic evaluation are included. The primary outcome 
for the study is social emotional well-being, assessed at 
20 months, using the ASQ:SE-2. Intention-to-treat and 
per protocol analyses will be conducted. Clustering and 
hierarchical effects will be accounted for using linear 
mixed models.
Ethics and dissemination Ethical approvals have been 
obtained from the University of York Education Ethics 
Committee (ref: FC15/03, 10 August 2015) and UK NHS 
REC 5 (ref: 15/WA/0178, 22 May 2015. The current 
protocol is Version 9, 26 February 2018. The sponsor of the 
trial is the University of York. Dissemination of findings will 
be via peer-reviewed journals, conference presentations 
and public events.
trial registration number ISRCTN11079129; Pre-results. 
strengths and limitations of this study
 ► Very few studies apply a proportionate universalism 
approach reflecting real-world provision of ser-
vices for families of very young children; within the 
Enhancing Social-Emotional Health and Wellbeing in 
the Early Years (E-SEE) intervention arm, there are 
three levels of intervention and four possible ‘doses’ 
of intervention according to need.
 ► The study includes an economic and process evalu-
ation, alongside the effectiveness evaluation.
 ► The design and implementation of this trial was in-
formed by a large randomised pilot study involving 
two research sites, over 200 families, and involving 
parent advisory committees.
 ► The study is inclusive of co-parents (typically fa-
thers) and will provide insights into the role of 
co-parents in shaping children’s social and emo-
tional development.
 ► The study cannot establish the effectiveness of each 
of the intervention’s three individual levels, that is, 
the study is only powered to explore the effective-
ness of the overall E-SEE steps model.
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IntroduCtIon 
Behavioural and mental disorders have become a public 
health crisis and by 2020 may surpass physical illness as a 
major cause of disability. Early intervention and preven-
tion of mental health and behavioural issues are more 
effective, and less costly, than late interventions.1 Child 
mental health issues are associated with significant costs 
to the individual and society and are associated with both 
short-term and long-term negative outcomes (eg, failure 
to thrive, school difficulties, drug/alcohol problems, 
juvenile delinquency, aggressive behaviour, adult mental 
health issues, ineffective relationship building, criminal 
activity), as well as becoming a young parent with the 
possibility of intergenerational transmission.2–4 There are 
clear benefits to parents, children and their families of 
reducing the potential for such difficulties to emerge, by 
improving the home environment, parenting skills, posi-
tive parent–child interactions and understanding of child 
development and safety issues.1 5 
Recent UK policy and guidance highlight the impor-
tance of improving health and well-being in children, 
with an emphasis on a whole family approach including 
fathers and grandparents in an integrated proportionate 
approach.6–8 The National Institute for Health and Care 
Excellence (NICE) guidance further suggests that the 
social and emotional well-being of vulnerable young 
children should be tackled through home visiting, early 
education and childcare.9 Several Cochrane reviews 
have highlighted the effectiveness of group-based parent 
programmes to promote child and parent well-being 
(3 years+),5 and a review of programmes for 0–3-year-olds 
calls for more research with younger age groups.10 Invest-
ment in evidence-based, early years intervention has the 
potential for long-term effects which will benefit wider 
society with attendant long-term cost benefits.1
Although there is significant policy interest and 
increasing research in this area, the evidence gap identi-
fied by NICE still exists. For example, the recent ‘Building 
Blocks’ Trial in England investigated a nurse-led intensive 
home visitation programme—called the Family Nurse 
Partnership (FNP)11—to evaluate the impact on infant 
and maternal outcomes up to 24 months after birth. 
The results showed that the FNP provided no additional 
short-term benefits with respect to the primary outcomes 
assessed in the trial.
The Incredible Years (IY) parent programmes ( www. 
incredibleyears. com) are manualised parent education 
and training interventions which include group-based 
components and parent and facilitator books and mate-
rials. IY is informed primarily by social learning theory and 
designed to enhance the social and emotional well-being 
of children aged 0–12 years. There is growing evidence of 
the cost-effectiveness of the IY parent programmes,12–14 
as well as concomitant reductions in health, social and 
education service utilisation.15 16 The IY Infant (IY-I) 
and IY Toddler (IY-T) versions, for 0–1 and 1–3-year-
olds, respectively, build on decades of development and 
research evidence of the IY (3 years+) programmes, but 
have not yet been rigorously evaluated in a UK, targeted, 
community-based trial. IY has the capacity to be delivered 
in a proportionate universalism model of varying doses 
according to need, and this study will be the first to eval-
uate such an approach in the form of our Enhancing 
Social-Emotional Health and Wellbeing in the Early Years 
(E-SEE) Steps model.
Aims and objectives
The study comprises two phases including: (1) a pilot trial; 
and (2) a definitive randomised controlled trial (RCT).
The pilot phase informed the main trial design and trial 
procedures including: (1) recruitment; (2) retention; (3) 
fidelity of intervention delivery; (4) model of delivery; (5) 
differentiation of outcome; and (6) outcome and cost-ef-
fectiveness measures. This protocol relates to the main 
trial only.
The main, definitive RCT is designed to: (1) estab-
lish the effectiveness of the IY programmes on clinical 
outcomes; (2) assess cost-effectiveness; and (3) evaluate 
the processes around service delivery.
Therefore, the main objectives and key questions of the 
trial are as follows:
 ► Does E-SEE Steps enhance child  social emotional 
well-being at 20 months of age when compared with 
services as usual?
 ► Is IY, and the proposed delivery model, cost-effective 
in enhancing child social emotional well-being at 20 
months when compared with services as usual?
 ► Can IY can be delivered as a proportionate univer-
salism model, and what are the organisational, or 
systems-level, barriers and facilitators to delivering in 
this way, with fidelity?
MEthods And AnAlysIs
design
A pragmatic two-arm RCT and economic appraisal, 
with an embedded process evaluation to examine the 
outcomes, implementation and cost-effectiveness of the 
intervention, as well as uptake by parents.
setting
Participating trial sites (local authorities) will not be 
offering IY-I or IY-T as part of usual services and should 
have sufficient live birth rates to support recruitment 
targets.
Intervention
The E-SEE Steps model includes two IY programmes—
IY-I and IY-T for parents of children aged 0–1 and 1–3 
years of age, respectively. Both programmes are deliv-
ered in a universal proportionate framework, to match 
varying parent–infant needs at different time points. All 
intervention parents will receive an IY-I book (universal 
level). Intervention parents may then be offered the IY-I 
(10 weeks, 2 hours/week) and/or IY-T (12 weeks, 2 hours/
week) group-based programme—based on a predefined 
threshold on the Patient Health Questionnaire (PHQ-9) 
and/or the Ages and Stages Questionnaire: Social 
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Emotional, Second Edition (ASQ:SE-2). Figure 1 depicts 
the proportionate universal approach of E-SEE Steps.
Delivery of IY-I and IY-T will take place in local commu-
nity settings such as children’s centres, with group sizes of 
up to 10 parents for IY-I and 14 parents for IY-T. Sessions 
will be delivered by two cofacilitators—a health profes-
sional (eg, health visitor, infant mental health practitioner, 
speech and language therapist) and/or early years chil-
dren’s services’ (or local authority commissioned) staff 
(eg, children centre worker or family support worker). 
Staff will be trained by accredited IY trainers. All interven-
tion participants will have access to services as usual.
Controls
Control group parents will receive services as usual.
Participants
Parents (primary caregivers who have the main parenting 
responsibility) of children aged 8 weeks or less will be iden-
tified by health staff, such as health visitors, or children’s 
centre staff, or via self-referral. A range of briefing events 
and information resources will be made available to staff 
in advance of the identification period. Parent contact 
details will be forwarded, with consent, to the research 
team who will arrange a home visit to provide further 
information on the study and assess eligibility status, and 
trained researchers will obtain written, informed consent 
(please see online supplementary files 1 and 2 for the 
information sheet and consent form). Consenting parents 
can invite a co-parent who shares parenting responsibili-
ties into the trial, so that we can explore the impact of 
co-parents on child well-being. The flow of participants 
through the trial is detailed in figure 2.
Inclusion and exclusion criteria for E-sEE trial
Inclusion criteria
Parents will be included if they consent to participate, 
have a child aged 8 weeks or under, will be willing to be 
randomised and, if allocated to intervention, will be able 
to receive the IY services offered.
Exclusion criteria
Child has obvious, or diagnosed, organic developmental 
difficulties. Parent is enrolled on another group parent 
programme at sign-up.
randomisation and allocation
Randomisation will be performed using a web-based 
randomisation system. Parents will be randomly allocated 
to intervention or control arms on a 5:1 ratio stratified 
according to level of need at baseline (BL) based on 
parent PHQ-9 or child ASQ:SE-2 score, gender of child 
and parent and recruitment site. The co-parent will auto-
matically receive the same allocation as the randomised 
parent.
Methods to reduce bias
Participants, IY facilitators and some of the study team 
will not be blind to allocation. Data collectors will be 
blind to participant allocation (parents will be asked not 
to share their allocation status)—as will participant refer-
rers, the chief investigator, the team statistician (until 
Figure 1 E-SEE Steps.
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final analysis), the Trial Steering Committee (TSC) and 
Trial Management Group (TMG).
Families will receive shopping vouchers of a modest 
amount (increasing at each data collection point to 
retain participants) as a token of thanks for completing 
measures.
Primary analysis will be intention to treat (ITT); once 
randomised, participants will remain within their allo-
cated group for analytical purposes even if they cross over 
to the other study arm, or drop out.
sample size calculations
Sample size is calculated on the child primary outcome 
of social emotional well-being—the ASQ:SE-2.17 We 
define the clinically important difference at follow-up 3 
(18 months post-BL) to be 5 units of the ASQ:SE-2 in the 
IY group when compared with services as usual (SAU). 
Assuming an SD value of 18 on the ASQ:SE-2 at follow-up 
3, the correlation between BL and follow-up 3 scores is 
0.26 and between pairs of measurements after BL is 0.40, 
the design effect of 1.25 for the IY arm, two-sided 5% 
Figure 2 Participant flow. IY-I, Incredible Years Infant; IY-T, Incredible Years Toddler.
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significance level and 90% power, we would require the 
study to have retained at follow-up 3441 in IY and 92 in 
SAU. Allowing for 12% overall attrition, 606 should be 
randomised with an allocation ratio of 5:1—to ensure 
sufficient parents (an expected total of 48) are eligible 
and able to attend IY groups.
outcome measures
A number of primary and secondary outcome measures 
will be completed at BL (within 10 weeks following birth) 
and then again at 2, 9 and 18 months post-BL (table 1). 
Data will be collected by trained researchers in the family 
home (or a venue of the participant’s choosing). Chil-
dren will be 20 months at final follow-up.
Child primary outcome
Social and emotional well-being
The parent-completed ASQ:SE-217 can be used for chil-
dren aged 1–72 months (with age-appropriate versions), 
and covers six key social and emotional development 
areas: self-regulation, compliance, adaptive functioning, 
autonomy, affect, social-communication and interaction 
with people. The measure is psychometrically sound with: 
a test-retest reliability of 89%, internal consistency of 84%, 
sensitivity is of 81% and specificity of 84%. The ASQ:SE-2 
takes 5–10 min to complete and will be used here, along 
with the PHQ-9 (see below), to assess eligibility for both 
the IY-I and IY-T groups.
Child secondary outcomes
Attachment/interaction
Independent observation of parent–child interaction will 
be undertaken using the CARE Index Infant/Toddler,18 
which is suitable for children aged 1–48 months. Three 
to five minutes of play is video recorded and later coded 
using an interaction classification scheme to assess global 
synchrony (ie, ‘At Risk’; ‘Intervention’; ‘Adequate’ and 
‘Sensitive’), parent attachment and child attachment over 
seven subscales. Inter-rater reliability is ≥0.75 for four of 
the seven subscales.
Cognitive development and health (quality of life)
The parent-completed Pediatric Quality of Life Inven-
tory (PEDsQL) Infant is a 45-item questionnaire for 
parents with infants aged 13–24 months.19 The measure 
has demonstrated internal consistency reliability for 
total scores (0.92) and is able to distinguish between 
healthy infants and those with acute and chronic 
illnesses.20 It takes 10 min to complete.
Child behaviour
The Strengths and Difficulties Questionnaire 2–4 
version (SDQ)21 is a 25-item widely used questionnaire 
designed for parents of children aged 2 to 4 years old. 
Research has shown good internal consistency for each 
of the five subscales and the overall ‘Total Difficulties’ 
score with this age group.22 This measure takes 10 min 
to complete.
Parent primary outcome
Depression
PHQ-9 is a 9-item self-complete tool to assess depression 
using criteria from the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-5). The total score provides 
an index of overall severity of depression.23 The PHQ-9 
has established good diagnostic validity evidencing 88% 
sensitivity and specificity for major depression.23 Cron-
bach alphas of 0.86 to 0.89 demonstrate good internal 
reliability, with a test-retest reliability at 0.84.24 The PHQ-9 
Table 1 Overview of measures
Outcomes and timepoints Measures Description BL Fu1 Fu2 Fu3
Social and emotional well-being ASQ:SE-2 Parent self-report √ √ √ √
Parent or co-parent depression PHQ-9 Parent/co-parent self-report √ √ √ √
Attachment CARE Index Parent observation √ √ √ √
Service use CSRI* Data collector administered √ √ √ √
Parenting skill PSoC Parent/co-parent self-report √ √ √ √
Parent or co-parent health EQ5D-5L Parent/co-parent self-report √ √ √ √
Demographics Bespoke form Data collector administered √
Short demographics Bespoke form Data collector administered √ √ √
Child health (and quality of life) PEDsQL Parent/co-parent self-report √ 
Attachment MPAS/PPAS† Parent/co-parent self-report √
Child behaviour SDQ Parent/co-parent self-report √
Average times to complete based on previous research carried out with similar populations by members of the research team.
*The Client Service Receipt Inventory (CSRI) description presented on p. 42 is taken from the original CSRI paper—for the E-SEE trial, we are 
using a revised, much shorter version, hence the variability in timings.
†Paternal Postnatal Attachment Scale (PPAS) to be used if father is the parent or co-parent.
ASQ:SE-2, Ages and Stages Questionnaire: Social Emotional, Second Edition; BL, baseline; Fu1, Follow-up 1; Fu2, Follow-up 2; Fu3, Follow-
up 3; MPAS, Maternal Postnatal Attachment Scale; PEDsQL, Pediatric Quality of Life Inventory; PHQ-9, Patient Health Questionnaire; PSoC, 
Parenting Sense of Competence questionnaire; SDQ, Strengths and Difficulties Questionnaire 2–4 version.
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takes 5 min to complete and will be used to assess eligibility 
to both IY-I and IY-T groups, along with the ASQ:SE-2.
Parent secondary outcomes
Maternal/paternal–child attachment/interaction
The Maternal Postnatal Attachment Scale (MPAS),24 
and the Paternal Postnatal Attachment Scale (PPAS)25 
contain 19 self-complete items developed to assess parent 
attachment to their infant. The MPAS has evidenced 
good internal consistency (0.78 to 0.79), high test-re-
test reliability (0.086) and good stability over time.24 For 
PPAS, internal consistency alpha levels are 0.62 to 0.81, 
with correlation coefficients 0.65 to 0.70, and exem-
plary convergent validity. MPAS/PPAS takes 10 min to 
complete.
Parenting skill
The Parenting Sense of Competence questionnaire 
(PSoC) has 17 self-complete items to assess parenting 
self-esteem.26 The measure has two subscales, related 
to parent satisfaction and parent self-efficacy. Internal 
consistency for the PSoC shows Cronbach’s alpha coeffi-
cients ≥0.70.26 The PSoC takes 5–10 min to complete.
Health (quality of life)
The EQ5D-5L,27 a five-item, self-complete measure that 
provides an index relating to quality of life over five 
domains: mobility, ability to self-care, ability to undertake 
usual activities, pain and discomfort, anxiety and depres-
sion. It also includes a visual analogue scale that records 
respondent’s reports of their overall health state from 
‘worst imaginable health state’ to ‘best imaginable health 
state’. The EQ5D-5L has been validated in several coun-
tries, including the UK.28 The EQ5D-5L takes 5–10 min to 
complete.
other outcomes
Demographic information will be captured via a bespoke 
structured interview form, including: age, ethnicity, reli-
gion, income, marital status, parent/co-parent education, 
housing and family composition.
Further economic evaluation outcomes
The study will examine resource use and costs based on 
access to health, social and educational services by parents 
and children as self-reported by parents using a modified 
Client Service Receipt Inventory.29 Costs of intervention 
delivery will be gathered via implementation staff and 
existing data sources.
Process evaluation
The embedded process evaluation will involve the comple-
tion of: weekly facilitator logs to record parental receipt 
of the IY-I book, and IY-I/IY-T attendance and contact 
rates; weekly self-rated IY checklists to assess adherence to 
core components; a researcher-rated Parent Programme 
Table 2 Brief summary of study timeline
Milestone Timing
Main trial phase study set-up April to September 2017
Sites 1 and 2
  Identification of potentially eligible participants October to December 2017
  Recruitment and baseline and data collection November 2017 to January 2018
  Intervention participants receive Incredible Babies book November 2017 to January 2018
  Follow-up one data collection January to February 2018
  Delivery of Incredible Years Baby Programme March to May 2018
  Follow-up two data collection August to September 2018
  Delivery of Incredible Years Toddler Programme January to March 2019
  Follow-up three data collection May 2019 to June 2019
  Process evaluation interviews and focus groups July 2019
Sites 3 and 4
  Identification of potentially eligible participants May to July 2018
  Recruitment and baseline and data collection June to August 2018
  Intervention participants receive Incredible Babies book June to August 2018
  Follow-up one data collection July to September 2018
  Delivery of Incredible Years Baby Programme October to December 2018
  Follow-up two data collection March to May 2019
  Delivery of Incredible Years Toddler Programme September to November 2019
  Follow-up three data collection December 2019 to January 2020
  Process evaluation interviews and focus groups February 2020
  Final report July 2020
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Implementation Checklist exploring adherence, quality 
of delivery and participant responsiveness30; and IY Parent 
Satisfaction Questionnaires (modified for UK audience 
in collaboration with the IY developer) completed after 
each session, and at the end of each programme.
statistical analysis
Statistical analyses will be conducted using validated statis-
tical software packages. ITT and per protocol analyses will 
be conducted.
treatment effectiveness
The study will examine the effectiveness of the treatment 
as a whole, over the three stages of the trial (2, 9 and 
18 month post-BL data collection time points). We will 
investigate the impact of each proportionate stage of the 
IY intervention in a secondary analysis. The overall effec-
tiveness of the proportionate delivery of IY will be assessed 
using a multilevel mixed model to examine treatment and 
time effects while allowing for the clustering by partici-
pant and group treatments and confounding and strati-
fying variables. The treatment is delivered in clusters but 
no cluster-based intervention occurs in the control arm. 
We will adhere to the most recent publication guidelines 
on the analysis of cluster-randomised trials.31 BL outcome 
measures will also be included as covariates. Missing data 
will be reported and multiple imputation will be used to 
impute missing values in the primary outcome.
Subgroup analyses will allow us to consider issues of 
inequalities and will include, for example, socioeconomic 
status, ethnicity, sex of primary caregiver, birth order of 
included child and co-parent outcomes to establish for 
whom the intervention works best, using mediator and 
moderator analyses.
Process evaluation/treatment processes
Service design support will facilitate the implementation 
of E-SEE Steps in each site, including evidenced-based 
strategies for engagement, retention and multiagency 
working.32 A service design manual for E-SEE Steps will be 
produced outlining programme theory, core components 
and intervention delivery.
A multimethod approach will assess fidelity of delivery, 
explore parents’, facilitators’ and service managers’ expe-
riences of E-SEE Steps as well as the organisational, team 
and individual factors that facilitate or hinder its imple-
mentation. Quantitative monitoring data (see outcome 
section for details) will be collected for all IY-I and IY-T 
groups.
Additionally, facilitators will complete online ques-
tionnaires before attending training in IY and again 
after completing delivery of the programme/s. The 
pretraining questionnaire will assess facilitators’ quali-
fications existing experience of parenting groups and 
working with families, as well as perceived competence 
to deliver the programme and perceived organisational 
support. The postdelivery questionnaire will supple-
ment the qualitative data on facilitators’ experiences of 
delivering IY-I/IY-T. All quantitative data will be reported 
descriptively.
Qualitative data will be gathered by means of 12 focus 
groups—half with intervention parents/co-parents and 
half with IY group facilitators—as well as 12 semistruc-
tured interviews with public health and children’s services 
managers. The focus groups and interviews will be under-
taken on completion of intervention delivery in each site 
to avoid potentially influencing the impact of the inter-
vention. All interviews and focus groups will be audio-re-
corded (with consent) and transcribed. Thematic analysis 
will be used to analyse qualitative data. Reporting of qual-
itative findings will adhere to the consolidated criteria for 
reporting qualitative research (COREQ).33
Economic evaluation
Cost-effectiveness analyses and cost-consequence anal-
yses will be conducted. The latter technique is useful in 
the evaluation of interventions with multidimensional 
outcomes. Costs in both trial arms will be estimated from 
alternative perspectives,34 including a National Health 
Service and Personal Social Services (PSS) perspective 
(consistent with that used by NICE),35 a wider public 
sector perspective and a societal perspective, which 
includes costs to participants.36 37
Resource use estimates will be collected from a 
variety of sources. A microcosting of IY-I and IY-T will be 
conducted (building on previous IY studies) to establish 
programme delivery costs (including consideration of 
set-up and training costs). This will include collecting 
the details of participants’ contacts with professionals 
required to deliver the intervention. Wider public sector 
resource use data, with a particular focus on health-
care (including primary and secondary care visits), and 
expenditure incurred ‘out-of-pocket’ by participants and 
absence from employment, will be collected from trial 
participants using questionnaires. Costs of resources will 
be calculated by applying published national (UK) unit 
cost estimates, where available, to estimates of relevant 
resource use.38 39 If published unit cost estimates are not 
available, unit costs will be identified in consultation with 
the appropriate finance departments of the resource 
provider. Costs and effects will be discounted at 3.5% per 
annum in line with national guidance.35 36
The initial analysis will present incremental results 
for the primary outcome measures for both children 
(ASQ:SE-2) and adults separately (PHQ-9). These will be 
compared with the incremental costs measured from the 
alternative perspectives as above. Secondary outcomes in 
terms of quality-adjusted life-years (based on PEDsQL for 
children and EQ-5D5L for adults) will also be considered. 
Alternative methods for combining different primary 
and secondary outcomes across children and adults and 
across outcomes will be explored to allow for a full assess-
ment of the benefits, which can then be compared with 
costs. Links between trial outcome measures and longer-
term outcomes (eg, across health and education sectors) 
will be explored.
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Probabilistic sensitivity analyses will be conducted to 
reflect the uncertainty around the adoption decision 
(depicted using cost-effectiveness acceptability curves).36 
Sensitivity analyses will be performed to determine the 
robustness of the results to altering certain assumptions; 
for example, changes in the assumed discount rate could 
influence the results.36 40
Patient and public involvement
During the preparation of the application for funding, 
three discussion groups were held, two with parents 
who had attended, or were currently attending, a parent 
programme and one with parents who had not attended 
a programme. Their input was invaluable to the design of 
the study.41 Four topics were discussed: recruitment to the 
study/engagement; retention of participants to parenting 
programmes; retention to study and data collection; and 
public involvement in research.
Parent peers were suggested as a means to engage and 
retain intervention participants to the programme/study. 
This was seen as particularly important to overcome 
barriers when engaging with fathers. Regarding data 
collection methods, attendees suggested giving a choice 
to parents but should be face-to-face. The design has 
incorporated home-based or community-based (eg, at a 
children centre) data collection visits. The setting up of a 
parent committee was recommended.
A parent committee will be set up to:
1. Assist parent engagement by holding preinterven-
tion sessions in community venues to discuss parent 
programmes—expectations and potential benefits. 
Service users believed peer support important for 
engagement due to: mistrust of some profession-
als, anxiety in attending a programme/discussing 
feelings.
2. Input to the development of information/consent 
forms and other literature to enhance inclusivity 
through ease of understanding, particularly for par-
ents with low literacy.
3. Assist measure selection based on user-friendliness.
4. Attend project steering group.
5. Assist in training researchers in interview/data collec-
tion methods through role play activities.
6. Organise a dissemination event for families to 
share results and encourage future programme 
participation.
Ancillary substudies
Four substudies are planned to explore:
1. The impact of co-parents on children’s social and emo-
tional well-being.
2. Access to health records and frequency/severity of 
hospital admissions.
3. Statistical design and analysis of trials evaluating com-
plex interventions.
4. Comparisons with complementary studies and existing 
data sets.
EthICs And dIssEMInAtIon
Ethics and governance
Participants will be informed that their personal data will 
be pseudonymised and related forms and questionnaires 
will be identified using a participant study number only. 
All hard copy data will be stored in a locked filing cabinet 
in accordance with data protection requirements for the 
retention of research data and study team institutional 
data management policies. Confidentiality would only be 
broken if required for safeguarding a vulnerable child or 
adult, with any action in accordance with the study site 
policies and procedures.
The ethical implications of obtaining data that may 
identify a participant as depressed, having suicidal 
thoughts and subject to domestic violence or potential 
child protection issues require appropriate safeguarding 
procedures to prevent any potential harm. Research site 
policies also require the reporting of potential child 
protection issues. Thus, we will implement the following 
safeguards:
1. Debriefing procedures
2. Providing information about sources of treatment
3. Special provisions for participants reporting severe de-
pression, suicidal thoughts or domestic violence, and 
potential child protection issues
4. Procedures for notifying adverse events.
The trial will follow appropriate Sheffield Clinical Trials 
Research Unit (CTRU) Standard Operating Procedures 
(SOPs), and also project-specific SOPs developed collab-
oratively with participating sites, the research team and 
the Parent Advisory Committee (PAC). A data manage-
ment plan details data storage and security standards and 
procedures.
Patient and public involvement is expected at all 
stages of the study. We will have PAC in each study site, 
comprising parents with similar demographics to the 
intended participants. PAC will advise and support both 
the study team and oversight committees about outcome 
tools, SOPs recruitment, retention and dissemination of 
results.
TSC (including a lay member), Data Monitoring and 
Ethics Committee (DMEC) and TMG have oversight of 
the trial. DMEC is independent and comprises an expert 
in the parenting field, statistician and health economist. 
Procedures are in place to notify the trial team about any 
adverse events identified during the course of the study, 
which will be reported to the oversight committees and 
regulatory/funding bodies as required. Sheffield CTRU 
conduct monitoring of trial conduct in line with an SOP.
data statement
Requests for participant-level quantitative data and statis-
tical codes should be made to the corresponding author 
and will be considered by members of the original TMG, 
including the chief investigator and members of Shef-
field CTRU, who will release data on a case-by-case basis. 
Data will be shared in line with the principles for sharing 
patient-level data as described by Smith et al.42 The data 
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will not contain any direct identifiers and we will minimise 
indirect identifiers and remove free text data to minimise 
the risk of identification.
dissemination
In consultation with PAC, promotional materials 
were developed to assist participant recruitment and 
to inform participants on study progress, results and 
outputs. Dissemination methods include: a project 
website; regular newsletters; social media; a parent case-
study DVD and infographics; national and international 
conferences, seminars and workshops; peer-reviewed 
publications; and other articles of professional interest. 
Knowledge exchange/translation events will be tailored 
to parents/major stakeholder groups including: policy 
makers, commissioners, service planners and managers, 
practitioners, researchers/academics.
trial status
On Friday, 17 August 2018, 314 participants have been 
enrolled in the main trial phase of the study, and 249 have 
received the universal dose of the IY Book. This trial is 
ongoing (see table 2 for timeline of a selection of study 
milestones; Trial Registration: ISRCTN 11079129, NIHR 
portfolio 1 73 946).
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